connect with us
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
crispr therapeutics, mgh team up on new cancer treatments
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
.
for years he was part of the defense that helped the new england patriots win three super bowl rings. now
.